| Literature DB >> 32996339 |
Andrew Jang1, Chris Brown1,2, Gillian Lamoury1,2,3, Marita Morgia1,3, Frances Boyle2,3, Isobel Marr1, Stephen Clarke1,2, Michael Back1,2,3, Byeongsang Oh1,2,3.
Abstract
BACKGROUND: Several studies have identified fatigue as one of the major symptoms experienced during and after cancer treatment. However, there are limited options to manage cancer related fatigue (CRF) with pharmacological interventions. Several acupuncture studies suggested that acupuncture has a positive impact on CRF. This review aims to assess the evidence of acupuncture for the treatment of CRF.Entities:
Keywords: acupuncture; cancer; cancer related fatigue; fatigue
Year: 2020 PMID: 32996339 PMCID: PMC7533944 DOI: 10.1177/1534735420949679
Source DB: PubMed Journal: Integr Cancer Ther ISSN: 1534-7354 Impact factor: 3.279
Figure 1.Flow chart.
Summary of Findings.
| Author | Study design | Population | Sample size | Intervention/control | Outcome measurement tools | Adverse effects | Results/conclusions |
|---|---|---|---|---|---|---|---|
| Cheng et al[ | RCT | Non-small cell lung cancer (NSCLC) | Total N = 28 | Both groups received 8 × 45 min sessions for 4 weeks (2 per week) | BFI-C and FACT-LCS | Measured with the CTCAE version 3.0 | A significant reduction in the BFI-C score was observed at 2 weeks in the 14 participants who received active acupuncture compared with those receiving the placebo ( |
| Balk et al[ | RCT | Women with localized cancer | Total N = 27 | Both groups received 2 × 30 min treatment for 4-6 weeks | Primary outcome: FACIT-F | No subjects reported adverse reaction | Both true and sham acupuncture groups had improved fatigue, fatigue distress, quality of life, and depression from baseline to 10 weeks, but the differences between the groups were not statistically significant. The true acupuncture group improved 5.50 (SE, ±1.48) points on the Functional Assessment of Chronic Illness Therapy-Fatigue Subscale (FACIT-F), whereas the sham acupuncture group improved by 3.73 (SE ±1.92) points. |
| Deng et al[ | RCT | Diagnosed with a malignancy | Total N = 97 | Both groups received 1 × 20 min treatment for 6 weeks | Primary outcome: BFI, HADS, FACT-G | Measured with the CTCAE version 3.0; bronchospasm (1), low blood counts (1), renal failure (2), secondary malignancy (1), nausea (1), vomiting (2), small bowel obstruction (1), dyspnea (1), and back pain (1). | BFI scores fell by about one point between baseline and follow-up in both groups with no statistically significant difference between groups. HADS and FACT-G scores also improved in both groups, but there was no significant difference between groups. |
| Johnston et al[ | RCT | Finished primary treatment for BCa | Total N = 13 | Both groups received 30 min education for 4 weeks for UC | Primary outcome: BFI | With a standardized checklist to assess for adverse events after each treatment, including bruising at needling site, panic, severe disorientation, fainting, infection, or puncture of an internal organ. | Compared to usual care control, the intervention was associated with a 2.38-point decline in fatigue as measured by the BFI (90% Confidence Interval from 0.586 to 5.014; |
| Mao et al[ | RCT | Women with a history of early stage of cancer (stages I-III) | Total N = 67 | Interventions twice weekly for 2 weeks, then weekly for 6 more weeks, for a total of 10 treatments over 8 weeks. | Primary outcome: BPI and BFI | Not reported | Compared with the WL condition, EA produced significant improvements in fatigue ( |
| Molassiotis et al[ | RCT | Patients with cancer who have completed chemotherapy | Total N = 47 | TA: had a 20-min acupuncture session needling 3 points (LI4, SP6, and ST36) bilaterally 3 times a week for 2 weeks | Primary outcome: MFI | Bleeding n = 2 | Significant improvements were found with regards to general fatigue ( |
| Molassiotis et al[ | Pragmatic RCT | BCs stage I, II, or IIIA | Total N = 302 | All trial patients received UC | Primary outcome: MFI | Not reported | The difference in the mean General Fatigue score, between those who received the intervention and those who did not, was 3.11 (95% CI, 3.97-2.25; |
| Molassiotis et al[ | Phase 3, unblinded pragmatic RCT. | BCa diagnosed stage I, II, or IIIa | Total N = 198 | All patients received 6 week 1 per week × 20 min acupuncture treatment, total of 6 treatments. | Primary outcome: MFI (GF) | Spot bleeding on acupuncture points | Primary outcome scores were equivalent between the therapist delivered acupuncture and self-acupuncture ( |
| Smith et al[ | A mixed method RCT | Women diagnosed with BCa | Total N = 30 | Both acupuncture groups received 3 week 2× per week 20 min acupuncture treatment and another 3 week 1× per week 20 min | Primary outcome: BFI | Not reported | There was a significant reduction in fatigue for women receiving acupuncture compared with control after 2 weeks mean difference (MD) 5.3, 95% CI 4.5 to 6.2, |
Abbreviations: AP, acupressure; SAP, sham acupressure; BCa, breast cancer; BFI, Brief Fatigue Inventory; CTCAE, Common Terminology Criteria for Adverse Events; CRFDS, cancer related fatigue distress scale; FACIT-F, Functional Assessment of Chronic Illness Therapy; SA, sham acupuncture; SF, self-acupuncture; SF-36, quality of life short form; TA, true acupuncture; UC, usual care; WL: wait list; EA, electro acupuncture; PSQI, Pittsburgh Sleep Quality Index; HADS, Hospital Anxiety and Depression Scale; W-BQ12, Well-being Questionnaire; MYCaW, Measure Yourself Concerns and Wellbeing; NSCLC, non-small-cell lung carcinoma.
Figure 2.Forest plot of the estimated of true acupuncture and sham acupuncture with cancer related fatigue.
Figure 3.Forest plot of the subgroup analyses of true acupuncture versus usual care.
Figure 4.Other fatigue estimates.
Figure 5.Risk of bias.